Search

WATCH: Israeli drug doubles survival time for patients with brain tumors

Professor Dror Harats, M.D., CEO of VBL Therapeutics, describes Phase III clinical trials of a cancer treatment in which a virus is injected intravenously and cuts off blood supply to solid tumors, shrinking cancerous growths.